MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 297 filers reported holding MEDIVATION INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $16,160,000 | +8.3% | 267,987 | -13.2% | 0.45% | +20.0% |
| Q4 2015 | $14,922,000 | +76.3% | 308,683 | +55.0% | 0.38% | +90.4% |
| Q3 2015 | $8,466,000 | -2.2% | 199,189 | +162.8% | 0.20% | +22.4% |
| Q2 2015 | $8,656,000 | -60.4% | 75,796 | -55.2% | 0.16% | -55.4% |
| Q1 2015 | $21,839,000 | -16.9% | 169,206 | -35.9% | 0.36% | -10.4% |
| Q4 2014 | $26,291,000 | -40.0% | 263,942 | -40.5% | 0.40% | -31.8% |
| Q3 2014 | $43,846,000 | – | 443,471 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |